TMP — Telemedycyna Polska SA Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Telemedycyna Polska SA is a Poland-based company engaged in provision of medical services via telephone, the Internet and radio waves. It operates Kardiotele system which enables cardiologic care and checks such as electrocardiogram (EKG) through telephone connection. Kariotele is addressed to individuals, as well as to nursing homes and rehabilitation centers. As of December 31, 2011, the Company operated one wholly owned subsidiary, Centrum Nadzoru Kardiologicznego Kardiofon Sp. z o.o.
Directors
- Bartosz Ostafinski CSU
- Lukasz Bula CMG
- Krzysztof Szalwa VSU
- Marzenie Krawiec VMG
- Marzenna Koczara-Gawlyta CAO
- Szymon Bula SUB
- Tomasz Dabrowski SUB
- Marcin Majewski SUB
- Ireneusz Rymaszewski SUB
- Last Annual
- Last Interim
- Incorporated
- April 1st, 2010
- Public Since
- August 18th, 2010
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 8,681,646
- Address
- ul. Ligocka 103, KATOWICE, 40-568
- Web
- https://telemedycynapolska.pl/
- Phone
- +48 323761455
- Auditors
Upcoming Events for TMP
Similar to TMP
Centrum Medyczne Enel Med SA
Warsaw Stock Exchange
Constance Care SA
Warsaw Stock Exchange
Eko-Oze SA
Warsaw Stock Exchange
EMC Instytut Medyczny SA
Warsaw Stock Exchange
Voxel SA
Warsaw Stock Exchange
FAQ
As of Today at 19:21 UTC, shares in Telemedycyna Polska SA are trading at PLN1.61. This share price information is delayed by 15 minutes.
Shares in Telemedycyna Polska SA last closed at PLN1.61 and the price had moved by +35.29% over the past 365 days. In terms of relative price strength the Telemedycyna Polska SA share price has outperformed the FTSE Global All Cap Index by +24.31% over the past year.
There is no consensus recommendation for this security.
Telemedycyna Polska SA does not currently pay a dividend.
Telemedycyna Polska SA does not currently pay a dividend.
Telemedycyna Polska SA does not currently pay a dividend.
To buy shares in Telemedycyna Polska SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN1.61, shares in Telemedycyna Polska SA had a market capitalisation of .
Here are the trading details for Telemedycyna Polska SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: TMP
Based on an overall assessment of its quality, value and momentum Telemedycyna Polska SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Telemedycyna Polska SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +13.89%.
As of the last closing price of PLN1.61, shares in Telemedycyna Polska SA were trading +20.9% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Telemedycyna Polska SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN1.61.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Telemedycyna Polska SA's management team is headed by:
- Bartosz Ostafinski - CSU
- Lukasz Bula - CMG
- Krzysztof Szalwa - VSU
- Marzenie Krawiec - VMG
- Marzenna Koczara-Gawlyta - CAO
- Szymon Bula - SUB
- Tomasz Dabrowski - SUB
- Marcin Majewski - SUB
- Ireneusz Rymaszewski - SUB